PT  - JOURNAL ARTICLE
AU  - Cascon, Ana
AU  - Shadwick, William F.
TI  - Predicting the course of Covid-19 and other epidemic and endemic disease
AID  - 10.1101/2021.12.26.21268419
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.12.26.21268419
4099  - http://medrxiv.org/content/early/2021/12/29/2021.12.26.21268419.short
4100  - http://medrxiv.org/content/early/2021/12/29/2021.12.26.21268419.full
AB  - The Gompertz Function is an accurate model for epidemics from Cholera in 1853 to Spanish Flu in 1918 and Ebola in 2014. It also describes the acute phase of annual outbreaks of endemic influenza and in all of these instances it has significant predictive power.For Covid-19, we show that the Gompertz Function provides accurate forecasts not just for cases and deaths but, independently, for hospitalisations, intensive care admissions and other medical requirements. In particular Gompertz Function projections of healthcare requirements have been reliable enough to allow planning for: hospital admissions,intensive care admissions,ventilator usage, peak loads and duration.Analysis of data from the ‘Spanish Flu’ pandemic and the endemic influenza cycle reveals alternating periods of Gompertz Function growth and linear growth in cumulative cases or deaths. Linear growth means the Reproduction Number is equal to 1 which in turn indicates endemicity.The same pattern has been observed with Covid-19. All the initial outbreaks ended in linear growth. Each new outbreak has been preceded by a period of linear growth and has ended with a transition from Gompertz Function growth to linear growth. This suggests that each of these outbreak cycles ended with a transition to endemicity for the current dominant strain and that the normal seasonal respiratory virus periods will continue to see new outbreaks. It remains to be seen if widespread vaccination will disrupt this cyclicality.Because both Gompertz Function Growth and linear growth are accurately predictable, the forecasting problem is reduced to identifying the transition between these modes and to improving the performance in the early Gompertz Function growth phase where its predictive power is lowest.The dynamics of the Gompertz Function are determined by the Gumbel probability distribution. This is an exceptional distribution with respect to the geometry determined by the affine group on the line which is the key to the role of the Gumbel distribution as an Extreme Value Theory attractor. We show that this, together with the empirically observed asymmetry in epidemic data, makes the Gompertz Function growth essentially inevitable in epidemic models which agree with observations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Covid-19 data presented in our analysis were taken from: Sweden: https://www.socialstyrelsen.se London: https://coronavirus.data.gov.uk Isle de France: https://www.data.gouv.fr Ontario: https://covid-19.ontario.ca Portugal: https://github.com/dssg-pt/covid19pt-data Amazonas and Rio de Janeiro: https://datasus.saude.gov.br/I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe Covid-19 data presented in our analysis were taken from: Sweden: https://www.socialstyrelsen.se London: https://coronavirus.data.gov.uk Isle de France: https://www.data.gouv.fr Ontario: https://covid-19.ontario.ca Portugal: https://github.com/dssg-pt/covid19pt-data Amazonas and Rio de Janeiro: https://datasus.saude.gov.br/ https://www.socialstyrelsen.se https://coronavirus.data.gov.uk https://www.data.gouv.fr https://covid-19.ontario.ca https://github.com/dssg-pt/covid19pt-data https://datasus.saude.gov.br/